Cargando…

Antileukoproteinase: modulation of neutrophil function and therapeutic effects in anticollagen II antibody-induced arthritis

Detalles Bibliográficos
Autores principales:	Burkhardt, H, Sehnert, B, Cavcic, A, Boehm, B, Nandakumar, K, Holmdahl, R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833891/ http://dx.doi.org/10.1186/ar901

Ejemplares similares

Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium
por: Sehnert, Bettina, et al.
Publicado: (2006)

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis
Publicado: (1982)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis
por: Uysal, Hüseyin, et al.
Publicado: (2009)

Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up
por: Manivel, Vivek Anand, et al.
Publicado: (2017)

The role of TLR4 and neutrophil expression in infection-triggered arthritis
por: Zhang, X, et al.
Publicado: (2004)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
por: Nandakumar, Kutty Selva, et al.
Publicado: (2004)

Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen
por: Bajtner, Estelle, et al.
Publicado: (2005)

Post-translational modification of type II collagen influences T-cell tolerance to self-type II collagen
por: Yamada, H, et al.
Publicado: (2003)

Neutrophils are the source of IL-17 and RANKL in zymosan induced arthritis
por: Milanova, Viktoriya I, et al.
Publicado: (2012)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
por: Sacri, AS, et al.
Publicado: (2011)

miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI
por: Quabius, Elgar Susanne, et al.
Publicado: (2017)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase
Publicado: (1996)

Identification of hnRNP-A2 (RA33) as a major B-cell and T-cell autoantigen in pristane–induced arthritis
por: Hoffmann, MH, et al.
Publicado: (2005)

Antibodies to ferritin in rheumatoid arthritis are associated with disease severity
por: Mewar, D, et al.
Publicado: (2005)

Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity
por: Carlsen, Stefan, et al.
Publicado: (2006)

Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis
por: Cascão, R, et al.
Publicado: (2010)

The innate immune system as a therapeutic target in arthritis
por: Corr, M, et al.
Publicado: (2003)

Genetic control of T-cell autoimmunity and arthritis
por: Holmdahl, R
Publicado: (2004)

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
por: Murias, S, et al.
Publicado: (2011)

Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Diagnostic value of different anti-citrullinated peptides antibodies in rheumatoid arthritis
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Human type II collagen is processed in lysosomal compartments of macrophages for presentation of the glycosylated arthritogenic epitope hCII(259–273 )to CD4 T cells in HLA-DR1 transgenic mice
por: von Delwig, A, et al.
Publicado: (2005)

PReS-FINAL-2107: In vitro investigation into mesenchymal stromal cells as a potential therapeutic in juvenile arthritis
por: Wienke, J, et al.
Publicado: (2013)

The use of animal models to find and understand arthritis genes
por: Holmdahl, R
Publicado: (2003)

Targeting MICA with therapeutic antibodies for the treatment of cancer
por: Bonnafous, Cécile, et al.
Publicado: (2013)

Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
por: Daia-Iliescu, Sînziana, et al.
Publicado: (2014)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
por: Isaacs, JD, et al.
Publicado: (2005)

IL-6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis
por: Yokota, S, et al.
Publicado: (2003)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients
por: Lamot, L, et al.
Publicado: (2008)

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

HLA II class alleles in juvenile idiopathic arthritis patients with temporomandibular joint involvement
por: Davidsone, Zane, et al.
Publicado: (2014)

The analysis of inflammatory cell migration using primary neutrophils
por: Avci, E, et al.
Publicado: (2015)

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils
por: Xu, Zhongwei, et al.
Publicado: (2023)

Expression of apolipoproteins L in neutrophils during sepsis
por: Akl, I, et al.
Publicado: (2015)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
por: Hernández, Raquel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7mi0g7ha4667hjp4eqpjbpiell